Xalkori (crizotinib)

Xalkori (crizotinib) is a prescription medicine used to treat people with metastatic non-small cell lung cancer (NSCLC), that is either ALK-positive or ROS1-positive, or people with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive.